BRIEF

on IFabric Corp (isin : CA45172X2032)

IFabric Corp Achieves FDA Medical Device Registration for Innovative Apparel

On April 30, 2024, iFabric Corp, a leader in textile and apparel innovations, announced that its subsidiary, Intelligent Fabric Technologies (North America) Inc. (IFTNA), has successfully obtained a U.S. Food and Drug Administration Medical Device Registration. This registration is for its apparel products that integrate multiple textile technologies.

Giancarlo Beevis, President and Chief Executive Officer of IFTNA, expressed this milestone as a significant advancement in combining textile technology with healthcare benefits. The FDA registration confirms the effectiveness and safety of their apparel products, marking IFTNA as a credible entity in healthcare solutions. This achievement not only enhances IFTNA's reputation but also facilitates future exploration of additional medical device registrations and expansion in the healthcare sector.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all IFabric Corp news